State Street SPDR S&P Pharmaceuticals ETF
XPH$56.91 -0.58 (-1.01%)
Dividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| December 24, 2025 | $0.11 | 2025-12-22 | 2025-12-22 |
| September 24, 2025 | $0.10 | 2025-09-22 | 2025-09-22 |
| June 25, 2025 | $0.10 | 2025-06-23 | 2025-06-23 |
| March 26, 2025 | $0.15 | 2025-03-24 | 2025-03-24 |
| December 26, 2024 | $0.15 | 2024-12-23 | 2024-12-23 |
Dividends Summary
- Consistent Payer: State Street SPDR S&P Pharmaceuticals ETF has rewarded shareholders with 84 dividend payments over the past 18 years.
- Total Returned Value: Investors who held XPH shares during this period received a total of $19.15 per share in dividend income.
- Latest Payout: The most recent dividend of $0.11/share was paid 30 days ago, on December 24, 2025.
- Yield & Schedule: XPH currently pays dividends quarterly with an annual yield of 0.82%.
- Dividend Growth: Since 2007, the dividend payout has decreased by 25.7%, from $0.15 to $0.11.
Company News
Unloved Gilead Due For Reversal On Flight-To-Safety Money Flows
Numerous drugs under development are projected to come to market later this year and next for Gilead. Read why I rate GILD stock a Buy.
Should You Invest in the SPDR S&P Pharmaceuticals ETF (XPH)?
Sector ETF report for XPH
5 Beaten-Down Top-Ranked ETFs to Buy for a Turnaround
We have highlighted five ETFs from different zones that have plunged the most so far this year but have a solid Zacks ETF Rank.
A Look at Pharma ETFs Post Q1 Earnings
Many industry bigwigs reported solid results, with some beating on earnings or revenues or both.
Is SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now?
Smart Beta ETF report for XPH
